Search research articles
Contact Us
Filters
Showing results (1-10 of 132) with videos related to
Page
of 14
Sort By:
Journal of Experimental Stroke & Translational Medicine
|
March 23, 2011
Clinical trial structures
Scott R Evans
Journal of Experimental Stroke & Translational Medicine
|
May 3, 2011
Fundamentals of clinical trial design
Scott R Evans
Journal of Experimental Stroke & Translational Medicine
|
March 23, 2011
Common statistical concerns in clinical trials
Scott R Evans
NEJM Evidence
|
February 6, 2024
Independent Oversight of Clinical Trials through Data and Safety Monitoring Boards
Scott R Evans
Journal of the National Cancer Institute
|
September 26, 2022
Weighing evidence: robustness vs quantity
Scott R Evans, Toshimitsu Hamasaki
Statistical Communications in Infectious Diseases
|
August 1, 2017
Evaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls?
Scott R Evans, John Powers
Statistics in Biopharmaceutical Research
|
April 25, 2017
Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step toward Pragmatism in Benefit:risk Evaluation
Scott R Evans, Dean Follmann
Statistics in Biopharmaceutical Research
|
April 19, 2016
Comment: Fundamentals and Innovation in Antibiotic Trials
Scott R Evans, Dean Follmann
Virulence
|
July 30, 2016
Methods and issues in studies of CRE
Scott R Evans, Anthony D Harris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 7, 2019
Reply to Humphrey and Spafford
Robert A Bonomo, Scott R Evans
Page
of 14
Search research articles
Search
Showing results (1-10 of 132) with videos related to
Sort By:
Page
of 14
Journal of Experimental Stroke & Translational Medicine
|
March 23, 2011
Clinical trial structures
Scott R Evans
Journal of Experimental Stroke & Translational Medicine
|
May 3, 2011
Fundamentals of clinical trial design
Scott R Evans
Journal of Experimental Stroke & Translational Medicine
|
March 23, 2011
Common statistical concerns in clinical trials
Scott R Evans
NEJM Evidence
|
February 6, 2024
Independent Oversight of Clinical Trials through Data and Safety Monitoring Boards
Scott R Evans
Journal of the National Cancer Institute
|
September 26, 2022
Weighing evidence: robustness vs quantity
Scott R Evans, Toshimitsu Hamasaki
Statistical Communications in Infectious Diseases
|
August 1, 2017
Evaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls?
Scott R Evans, John Powers
Statistics in Biopharmaceutical Research
|
April 25, 2017
Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step toward Pragmatism in Benefit:risk Evaluation
Scott R Evans, Dean Follmann
Statistics in Biopharmaceutical Research
|
April 19, 2016
Comment: Fundamentals and Innovation in Antibiotic Trials
Scott R Evans, Dean Follmann
Virulence
|
July 30, 2016
Methods and issues in studies of CRE
Scott R Evans, Anthony D Harris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 7, 2019
Reply to Humphrey and Spafford
Robert A Bonomo, Scott R Evans
Page
of 14